UNITEDHEALTH GROUP INCUNH

UnitedHealth Group generated $447.6 billion in revenue in FY2025, yet saw its earnings from operations collapse by 41% to $19.0 billion as medical care activity severely outpaced pricing assumptions. The core investment reality is clear: while the business reliably drives double-digit top-line expansion across its insurance and health services segments, profitability is increasingly constrained by structural cost spikes and Medicare Advantage funding reductions.

The sheer scale of the enterprise has expanded relentlessly, with total revenue growing from $287.6 billion in FY2021 to $447.6 billion in FY2025. UnitedHealthcare and Optum Rx drove a combined 16% revenue increase in the latest fiscal year. However, mounting expense pressures have aggressively compressed margins. In Q3 2025, medical costs surged 21% to $80 billion, driving the Medical Care Ratio up to 89.9%. This operational strain followed a turbulent FY2024, where the company absorbed a $7.98 billion net loss primarily driven by an $8.3 billion hit from divesting its South American operations and $2.2 billion in direct response costs from the Change Healthcare cyberattack.

Investors have adjusted expectations to reflect these intensifying cost dynamics and internal restructuring efforts. At the close of FY2025, the market valued the healthcare provider at a $299.1 billion market cap. Shares closed at $330.11, representing a multiple of 25.0x trailing earnings.